[chrsw]

Making drugs isn't about understanding. It's about educated guesses and lots of trial and error. Biotech funding has no patience for deep understanding.

Most drug research ends up as a money sink because investors lose patience watching scientists play whack-a-molecule.

Some drugs end up making a lot of their money for intended uses that aren't directly related to the initial research. It's easier (and cheaper) to repurpose known drugs for new indications.

Rethinking biology is a terrible pitch but it's probably the only way we will get true breakthroughs that go beyond symptom cover up.